Founded by medical practitioners and clinical researchers, Medimaps combines Swiss innovation with a global presence to lead in bone health management.​ We provide healthcare professionals worldwide with advanced AI-driven software that enables comprehensive bone microarchitecture assessment. 

Our passion for musculoskeletal health is underpinned by scientific knowledge, collaborations with world-class academics, clinicians, industry partners, and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core of our company’s DNA.​

What we do

As the pioneer and leader in clinical routine bone microarchitecture assessment, we develop innovative medical imaging AI applications. We transform bone health management and improve treatment decision-making for enhanced patient care. ​
Medimaps also partners with pharmaceutical and medical device companies by providing professional services in the development of novel osteoporosis and orthopedic treatments.

Guided by our mission and a robust business governance, we aim to support healthcare professionals in improving patients’ quality of life.

Our vision

Our vision is to create an era where healthy bones are the norm.

Our mission

Our mission is to transform complex clinical needs into straightforward routine solutions that seamlessly integrate into healthcare workflows. ​

We strive to deliver unparalleled insights that enable timely diagnosis and treatment of bone fragility, elevating standards of care and improving quality of life for healthy aging.​